On Sunday, June 21, hundreds of teammates will come together to run the 2020 Boston Athletic Association’s (B.A.A.) 10K® road race to support the Brigham.
The Waldor Lab at the Brigham, is developing a ground-breaking oral cholera vaccine called HaitiV (see Hubbard et al. Science Translational Medicine 13 Jun 2018: Vol. 10, Issue 445).
The vaccine acts as a fast-acting probiotic that decreases Vibrio cholerae infection from taking hold as well as a traditional vaccine, which educates the immune system inducing production of antibodies that kill Vibrio cholerae bacteria (Sit et al. PLoS Negl Trop Dis. 2019 May 31;13(5):e0007417).
This fast-acting vaccine promises to revolutionize cholera outbreak control.
The Waldor Lab at the Brigham is conducting a Phase I clinical trial in 2020 to test this new vaccine in human volunteers.
By supporting team Cholera Crushers as a member of the Brigham B.A.A. 10K fundraiser, YOU can help fund our Phase I clinical trial!
Money our team raises will go directly to Dr. Waldor's general research fund at the Brigham and will be used to produce the vaccine doses for the trial.